Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle”, says Roberts.
To continue reading, today with our introductory offers
Advertisement
More from New Å®ÉúСÊÓƵ
Explore the latest news, articles and features
Mind
The relationship recession is even bigger for Gen Z than we thought
News
Technology
Killer robots are here – we must finally decide whether to accept them
Leader
Technology
Quantum computer quickly mines cryptocurrency while using less energy
News
Mind
How to sparkle in conversation with strangers
Comment
Popular articles
Trending New Å®ÉúСÊÓƵ articles
1
Understanding anorexia’s grip on the brain could unlock new therapies
2
Fully autonomous drones have killed human soldiers for the first time
3
Millions of fossil whale bones found in deep-ocean ‘necropolis’
4
You could get some of the benefits of sleep without having to nod off
5
Explore the mind-bending and paradoxical art of M C. Escher
6
The relationship recession is even bigger for Gen Z than we thought
7
‘Forgotten’ pollutants cause 15 per cent of global warming
8
The looming El Niño could be bad – but much worse is to come
9
Toy universe shows that time could be a quantum illusion
10
Mysterious ‘cold blob’ in the Atlantic suggests the AMOC is weakening
